Solesis will begin operations in the spring of 2025 in the Greenpark Free Trade Zone, the first environmentally sustainable industrial park and Free Trade Zone in Latin America.
The biopharmaceutical manufacturer plans to invest $6.1 million to establish a standalone facility in Virginia.
Leaps and bounds at life sciences companies have spurred evolution in site selection decisions.
Scorpion Biological Services' new 500,000-square-foot biomanufacturing facility will create 500 jobs in Manhattan, KS.
Resources, support and a history of innovation make Delaware an ideal location for bioscience and advanced manufacturing